Home

Piramal Pharma PE Ratio

Image

Piramal Pharma Ltd

NSE: PPLPHARMA

PE

302.3

Last updated on: May 15, 2025

Key Highlights

  • The P/E Ratio of Piramal Pharma Ltd is 302.3 as of 15 May 15:30 PM .
  • The P/E Ratio of Piramal Pharma Ltd changed from 991.5 on March 2024 to 991.5 on March 2024 . This represents a CAGR of 0.00% over 1 years.
  • The Latest Trading Price of Piramal Pharma Ltd is ₹ 208.55 as of 15 May 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 21.1 to 40.1 in 5 years. This represents a CAGR of 13.70%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 26.2. The PE Ratio of Pharmaceuticals industry is 40.1. The PE Ratio of Retail industry is 139.8. The PE Ratio of Textiles industry is 37.1 in 2024.

Historical P/E Ratio of Piramal Pharma Ltd

No data available

Company Fundamentals for Piramal Pharma Ltd

Image

Piramal Pharma Ltd

NSE: PPLPHARMA

Share Price

₹ 208.55

-10.45 (-4.77%)

stock direction

Last updated on: May 15, 2025

Market Price of Piramal Pharma Ltd

1M

1Y

3Y

5Y

Monitoring Piramal Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
15 May 2025208.55
14 May 2025219
13 May 2025214.9
12 May 2025211.95
09 May 2025207.9
08 May 2025206
07 May 2025213.65
06 May 2025206.7
05 May 2025212.25
02 May 2025211.2

SWOT Analysis Of Piramal Pharma Ltd

Strength

3

che

Weakness

1

che

Opportunity

0

che

Threats

1

che

BlinkX Score for Piramal Pharma Ltd

Asset Value vs Market Value of Piramal Pharma Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Piramal Pharma Ltd27648
Sun Pharmaceutical Industries Ltd417400
Divis Laboratories Ltd164844
Cipla Ltd121328
Torrent Pharmaceuticals Ltd110516
Mankind Pharma Ltd105632

PE Ratio of Piramal Pharma Ltd Explained

27648

Market cap

91

Earnings

302.3X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Piramal Pharma Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Piramal Pharma Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Piramal Pharma Ltd

No data available

* All values are in %

About Piramal Pharma Ltd

  • Piramal Pharma Limited was incorporated on March 4, 2020 as a Public Limited Company and registered with the RoC. The Company offers a portfolio of differentiated products and services through end-to-end manufacturing capabilities across 17 global facilities and a global distribution network in over 100 countries.
  • It includes an integrated CDMO business, CHG business and ICH business, selling over-the-counter products in India.
  • In addition, it has a joint venture with Allergan, a leader in ophthalmology in the Indian formulations market. PPL is a leading pharmaceutical company with global operations, providing end-to-end pharma services to customers and a portfolio of differentiated pharma products across a domestic and global distribution network.
  • It operate under three business verticals - Piramal Pharma Solutions, an integrated contract development and manufacturing organization (CDMO) having a product suite in niche areas such as highly potent Active pharmaceutical ingredients (APIs), Finished dosage forms (FDFs), antibody drug conjugates, potent sterile injectable, hormonal oral solid dosage forms, biologics and vaccines; Piramal Critical Care, a complex hospital generics (CHG) business in the areas of inhalation anaesthesia, injectable anaesthesia and pain management, intrathecal therapy and other injectable; and India consumer healthcare (ICH) business, selling well-known OTC brands.

Piramal Pharma Ltd News Hub

Piramal Pharma receives SBTi validation for its GHG commitment

Piramal Pharma has embarked on its sustainability journey as the Science Based Targets initiative (S

Read more

17 Sept 24

Piramal Pharma to invest $80M to expand its Lexington, Kentucky facility

Piramal Pharma Solutions (PPS), a leading global Contract Development and Manufacturing Organization

Read more

30 Sept 24

Piramal Pharma to discuss results

Piramal Pharma will hold a meeting of the Board of Directors of the Company on 28 January 2025. Powe

Read more

14 Jan 25

Piramal Pharma to declare Quarterly Result

Piramal Pharma will hold a meeting of the Board of Directors of the Company on 23 October 2024. Powe

Read more

15 Oct 24

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Piramal Pharma Ltd

What is the current PE Ratio of Piramal Pharma Ltd?

The Current PE Ratio of Piramal Pharma Ltd is 302.25 as on 15 May 2025.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.1 as on 15 May 2025.

What was the PE Ratio of Piramal Pharma Ltd last year?

The PE Ratio of Piramal Pharma Ltd was 0.0 last year, now the PE ratio is 302.25, showing a year-on-year growth of -%.

What does the PE Ratio of Piramal Pharma Ltd indicate about its stock?

The PE Ratio of Piramal Pharma Ltd is 302.25. This ratio indicates that investors are willing to pay 302.25 times the earnings per share for each share of Piramal Pharma Ltd.

What is the PE Ratio Growth of Piramal Pharma Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Piramal Pharma Ltd grew by -% whereas, the EPS ratio grew by 3766.7.

How does the PE ratio of Piramal Pharma Ltd compare to industry peers?

The PE ratio of Piramal Pharma Ltd PE Ratio can indicate whether it is overvalued or undervalued compared to competitors in the same industry. A lower PE ratio may suggest an undervalued stock, while a higher PE ratio could indicate premium pricing.

Is a high PE ratio for Piramal Pharma Ltd PE Ratio good or bad?

A high PE ratio may indicate strong future growth expectations, but it can also suggest overvaluation. It is best to compare it with industry averages and historical trends of Piramal Pharma Ltd PE Ratio.

What factors influence the PE ratio of Piramal Pharma Ltd PE Ratio?

The PE ratio of Piramal Pharma Ltd PE Ratio is influenced by factors such as earnings growth, investor sentiment, macroeconomic conditions, and sector trends.

How often does the PE ratio of Piramal Pharma Ltd PE Ratio change?

The PE ratio changes as the share price or earnings of Piramal Pharma Ltd PE Ratio fluctuate, and it is updated whenever there is a significant movement in either of these factors.

Where can I find the latest PE ratio of Piramal Pharma Ltd PE Ratio?

You can check the latest PE ratio of Piramal Pharma Ltd PE Ratio on BlinkX Website above or any other stock market platforms, or at the company’s official website.

What is a good PE ratio for Piramal Pharma Ltd PE Ratio?

A "good" PE ratio depends on industry standards and market conditions. It is advisable to compare Piramal Pharma Ltd PE ratio with its historical average and competitors.

Can the PE ratio of Piramal Pharma Ltd PE Ratio predict future stock performance?

While the Piramal Pharma Ltd PE ratio is a useful indicator of valuation, it should be used alongside other financial metrics and market analysis to make informed investment decisions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions